(Press-News.org) A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new study by an international research group led by Umeå University, Sweden, and the Medical University of Vienna, Austria. By blocking a receptor for the hormone, the growth of tumour cells in the prostate was inhibited. In the long term, the discovery may open up a new way of attacking certain types of aggressive prostate cancer.
"The results indicate that the receptor in question is a driving force in the growth of cancer. Substances that block it could thus be a target for future drugs against prostate cancer," says Lukas Kenner, visiting professor at Umeå University and the one who has led the study that is published in Molecular Cancer.
The receptor in question is called thyroid hormone receptor Beta, TRβ. It binds the thyroid hormone triiodothyronine, T3. In laboratory experiments, the activation of T3 has led to a sharp increase in the number of prostate cancer cells. However, when the receptor TRβ was inhibited with the help of an active substance, NH-3, significantly reduced the growth of cancer cells. NH-3 is a substance that is only used in research to block TRβ.
The substance's effect on cancer was then confirmed in animal experiments in mice. Tumours treated with NH-3 remained smaller or progressed significantly more slowly. This was shown to be particularly effective in models of prostate cancer that are so-called castration resistant. This means that the tumour continues to grow despite treatment that reduces the amount of the male sex hormone testosterone, which usually drives cancer growth. This form is currently difficult to treat clinically.
Blocking TRβ using NH-3 worked by leading to the elimination of a particular signal, the androgen receptor signal, which is otherwise activated by testosterone and then plays a central role in the development of prostate cancer.
A review of data from cohorts of patients with prostate cancer supports these findings. In tissue samples, elevated levels of TRβ could be seen in tumours in the prostate compared to those in healthy tissue. In addition, genetic analyses show that mutations in many prostate cancer patients alter the signalling pathways for thyroid hormone. This suggests that blocking the thyroid hormone and its receptor may be a target for further research to find new treatments for prostate cancer.
"Of course, it is a balancing act not to change the hormonal balance in the thyroid gland more than necessary to fight cancer in another part of the body, and it will probably not be a solution for all types of prostate cancer. Further research will have to answer what a treatment could look like, possibly in combination with other treatments. Of course, this is an interesting track," says Lukas Kenner.
Prostate cancer is the second most common form of cancer among men in the world. When detected early, the disease is usually treated by reducing the amount of testosterone. However, many patients become resistant to this treatment, and as a result, the number of available treatments is limited.
END
Thyroid gland new possible target for prostate cancer treatment
2025-11-10
ELSE PRESS RELEASES FROM THIS DATE:
New study reveals devastating impact of cane toads approaching the Pilbara
2025-11-10
New Curtin University research has found invasive cane toads are on track to reach Western Australia’s Pilbara region within the next 10 to 20 years, threatening to cause widespread losses among native species and significant cultural and economic harm.
The study, published in Scientific Reports, predicts that without containment efforts, the toxic amphibians will colonise up to 75 per cent of the Pilbara within three decades, putting 25 native species at risk of serious population declines. These include several species of native marsupial predators like northern quolls, ghost bat and kaluta, as well as frog-eating snakes, blue-tongue skinks and goannas.
Of ...
COP30: Global nature goals at risk as conservation projects quietly fail
2025-11-10
As world leaders begin COP30 climate negotiations in Brazil this week, an international team co-led by a University of Sydney researcher has warned of a hidden crisis undermining global biodiversity and carbon targets: the quiet abandonment of conservation projects.
The comment paper, ‘Conservation abandonment is a policy blind spot’, published in Nature Ecology & Evolution, was co-led by Dr Matthew Clark, a postdoctoral researcher in the Thriving Oceans Research Hub at the University of Sydney and an honorary research associate in the Centre for Environmental Policy at Imperial College ...
New treatment for combating iron deficiency more effectively
2025-11-10
Iron deficiency is globally widespread. Women are particularly affected, with one in five in Europe suffering from iron deficiency. The consequences are anaemia, constant fatigue, chronic headaches and a weakened immune system. Researchers led by ETH professor Raffaele Mezzenga have now developed a new dietary supplement that could efficiently treat iron deficiency and anaemia. This development is being co-led by Michael B. Zimmermann, professor emeritus at ETH Zurich. The preparation consists of edible oat protein ...
A new AI-powered method to automate material analysis and design
2025-11-10
Understanding the properties of different materials is an important step in material design. X-ray absorption spectroscopy (XAS) is an important technique for this, as it reveals detailed insights about a material’s composition, structure, and functional characteristics. The technique works by directing a beam of high-energy X-rays at a sample and recording how X-rays of different energy levels are absorbed. Similar to how white light splits into a rainbow after passing through a prism, XAS produces a spectrum of X-rays with different energies. This spectrum is called as spectral data, which acts like an unique fingerprint of a material, ...
Security flaws in portable genetic sequencers risk leaking private DNA data
2025-11-10
Portable genetic sequencers used around the world to sequence DNA have critical, previously unreported security vulnerabilities that could reveal or alter genetic information without detection, according to a new study.
Researchers from the University of Florida have, for the first time, exposed these security risks in devices from Oxford Nanopore Technologies, which produces nearly all the portable genetic sequencers in the world.
Alerted by the security researchers, Oxford Nanopore Technologies has rolled out updated software to patch the vulnerabilities. But out-of-date software, or unsecured internet systems, could still leave some DNA sequencers vulnerable ...
‘Roadmap’ shows the environmental impact of AI data center boom
2025-11-10
ITHACA, N.Y. - As the everyday use of AI has exploded in recent years, so have the energy demands of the computing infrastructure that supports it. But the environmental toll of these large data centers, which suck up gigawatts of power and require vast amounts of water for cooling, has been too diffuse and difficult to quantify.
Now, Cornell researchers have used advanced data analytics – and, naturally, some AI, too – to create a state-by-state look at that environmental impact. The team found that, by 2030, the current rate of AI growth would annually put 24 to 44 million metric tons of carbon dioxide into the ...
Scientists discover chameleon’s telephone-cord-like optic nerves once overlooked by Aristotle and Newton
2025-11-10
Chameleons’ wandering eyes have fascinated and puzzled scientists since the days of ancient Greece. Now, after millennia of study, modern imaging has revealed the secret of their nearly 360-degree view and uncanny ability to look in two different directions at once. Behind their bulging eyes lie two long, coiled optic nerves — a structure not seen in any other lizard.
“Chameleon eyes are like security cameras, moving in all directions,” explained Juan Daza, associate professor at Sam Houston State University and author of a new study describing the trait. “They ...
One enzyme could be behind alcohol addiction and liver disease
2025-11-10
AURORA, Colo. (November 10, 2025) – Scientists have uncovered a surprising connection between sugar metabolism and alcohol addiction, identifying a potential new therapeutic target for treating alcohol-associated liver disease (ALD) and alcohol use disorder (AUD).
In a new study, out today in Nature Metabolism, University of Colorado Anschutz researchers found that alcohol triggers a metabolic pathway in the body that leads to the internal production of fructose, the same type of sugar commonly ...
Neanderthal DNA helps explain how faces form
2025-11-10
Every human face is unique, allowing us to distinguish between individuals. We know little about how facial features are encoded in our DNA, but we may be able to learn more about how our faces develop by looking at our ancient relatives, the Neanderthals. Neanderthal faces were quite distinctive from our own, with large noses, pronounced brows and a robust lower jaw. Now, scientists from the MRC Human Genetics Unit in the Institute of Genetics and Cancer at the University of Edinburgh, UK, are using the DNA of our extinct ...
New nasal vaccine has potential to transform respiratory disease prevention
2025-11-10
A research team from Trinity College Dublin has unveiled a groundbreaking new approach to vaccination that could redefine how we protect against respiratory infections. In a landmark study published in Nature Microbiology, the team demonstrated that their nasally-delivered, antibiotic-inactivated Bordetella pertussis (AIBP) vaccine not only prevents severe disease but also curbs bacterial transmission — an achievement long sought by vaccine developers worldwide.
The work, led by Professor Kingston Mills and Dr Davoud Jazayeri of Trinity’s School of Biochemistry ...